Interius BioTherapeutics

Interius BioTherapeutics

  • Founded: 2019
  • Location: Philadelphia, PA
  • Employee range: 1 - 10
  • Clinical stage: RD
  • Therapy area: Hematological malignancies
  • Drug types: ONC
  • Lead product: Undisclosed
  • Product link:
  • Funding: $76M A May 2021

job board

Short description:

Novel methods for in vivo cell-specific gene delivery

Drug notes:

Contact us to add description:

Long description:

Interius Biotherapeutics is developing cell and gene therapies to treat cancer. Chimeric antigen receptor (CAR) T-cell therapies involve removing and engineering patient T cells to recognise cancerous cells. Interius is instead focused on engineering T cells directly in vivo, bypassing the need for ex vivo manipulations and the potentially toxic pre-conditioning chemotherapy. This approach will involve development of next generation delivery technology so that the right cells are given the right payload for the right disease. Interius is in preclinical stages currently investigating viral-mediated delivery modalities to quantitate strength and purity and is also developing applications beyond immuno-oncology.


Interius BioTherapeutics
Clinical Research Associate
JE|6 days ago
Interius BioTherapeutics
Manager, Human Resources
JE|13 days ago
Interius BioTherapeutics
Sr. Manager, Project Management (Clinical)
JE|16 days ago
Interius BioTherapeutics
Sr. Scientist, Drug Product Development
JE|23 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy